Company Profiles

driven by the PitchBook Platform

Advent Pharmaceuticals

Description

Operator of a drug development company. The company focuses on developing inhaled drug products for the treatment of asthma and other pulmonary diseases.

2001

Founded

PRIVATE

Status

Early Stage VC

Latest Deal Type

3

Investors

Description

Operator of a drug development company. The company focuses on developing inhaled drug products for the treatment of asthma and other pulmonary diseases.

Website:

www.advent-pharma.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals
Drug Delivery

Primary Office

23 Normanby Road Notting Hill, Victoria 3168Australia +61 (0)3 9544 8785
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Advent Pharmaceuticals's full profile, request a free trial.

    Advent Pharmaceuticals Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Advent Pharmaceuticals Investors (3)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    CM CapitalVenture CapitalMinority000 0000000 0000
    Individual InvestorAngel (individual)Minority000 0000000 0000
    QIC BioVenturesVenture CapitalMinority000 0000000 0000
    CM Capital Venture Capital
    Individual Investor Angel (individual)
    QIC BioVentures Venture Capital

    Advent Pharmaceuticals Executive Team (1)

    NameTitleBoard
    Seat
    Contact
    Info
    Kenneth WindleChief Executive Officer, Chairman & Managing Director
    Kenneth Windle Chief Executive Officer, Chairman & Managing Director
    Request full access to PitchBook